South Korean investment firm SK Holdings got a start in contract manufacturing last year by snatching up a discarded Big Pharma plant in Europe. Now it has made a move on the U.S. with a deal to buy AMPAC, a
read more“The ‘NHS Challenge’ is designed specifically for agencies that have strong experience in dealing with UK specific challenges,” says the executive steering group’s Eric Hansen. More: Put your agency in the spotlight, ENTER NOW Source: News
read morePharmaTimes Media has announced the Medical & Scientific Excellence Awards as the latest addition to its highly prestigious portfolio of events – and now is the time to enter! More: Recognising the outstanding achievements of medical and scientific professionals Source:
read more“There is always a danger that health issues are not kept to the fore” in negotiations, says Niall Dickson More: Brexit ambition is ‘fine’ but execution is key, says Brexit Health Alliance Source: News
read moreJanssen says it is disappointed that NHS cost regulators are not backing NHS use of Darzalez (daratumumab) plus bortezomib and dexamethasone (DBd) for previously treated multiple myeloma in adults. More: NICE turns down Darzalex combo for pre-treated multiple myeloma Source:
read moreGlaxoSmithKline has sold rights to an experimental therapy being developed for psoriasis and dermatitis to Dermavant in a deal worth $330 million. More: GSK sells psoriasis/dermatitis therapy to Dermavant Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals